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To the Editor: We thank Drs. Hao, Li and Hu [1] for their comments on our recent article published on the effect of recurrent acute pancreatitis in the absence of overt chronic pancreatitis (RAP) on quality of life [2] . We appreciate the opportunity to respond on behalf of our co-authors.
In respect to the first point regarding the heterogenous definition of RAP, we agree that there are different intervals between attacks used to define RAP. For the purposes of the North American Pancreatitis Study 2 (NAPS2), the source of data for this study, RAP was determined at the discretion of the treating physician; therefore, the interval between attacks is not known [3] . However, as all of the enrolling physicians in the NAPS consortium are expert pancreatologists and the definition of chronic pancreatitis was quite rigorous, the probability of including patients with obvious chronic pancreatitis as RAP is quite low.
In regard to their second and third points, the diagnosis of endocrine insufficiency was reported by the physicianinvestigator based on work up to the time of enrollment into the study, including repeated elevations in blood sugar, hemoglobin A1c or use of antidiabetic medications. As such, the diagnosis of endocrine insufficiency in our study being attributable solely to transient elevations in blood sugar levels during an episode of acute pancreatitis is unlikely. We agree with Dr. Hao, Li and Hu that it can be important to differentiate between Type 2 and 3c diabetes, but for the purposes of this quality of life study, we believe this differentiation is less important. Most important was the fact that having diabetes, regardless of type, negatively affected the patient's quality of life score.
ConfliCt of interest:
Guarantor of the article: Gregory A. Cote MD, MS. Specific author contributions: Drafting the manuscript. Each author has approved the final draft submitted. Financial support: None. Potential competing interests: None.
